Jade Biosciences (JBIO) Enterprise Value (2021 - 2026)
Jade Biosciences (JBIO) recorded Enterprise Value of $950.97 million in Q2 2026, up 805.7% from $105 million a year earlier and up 148.9% from the prior quarter.
Powered by 
Analysis
Jade Biosciences (JBIO) Enterprise Value (2021 - 2026) Analysis & Trends
On a TTM basis, Jade Biosciences' Enterprise Value came in at $104.59 million as of Jun 30, 2026; for FY2025, it was $555.54 million, down 77.7% from FY2024.
- Annual Enterprise Value has declined for three straight years, with a four-year compound annual growth rate of -42.0% (FY2021 to FY2025).
- Across earlier years, Enterprise Value came in at $2.5 billion in FY2024 (-88.6%), $21.87 billion in FY2023 (-13.3%), $25.22 billion in FY2022 (+414.2%) and $4.91 billion in FY2021.
- The Q2 2026 figure is the highest quarterly Enterprise Value since Q1 2025.
- On a year-over-year basis, Enterprise Value rose in 1 of the last eight quarters, with growth averaging 23.7%.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 805.7% in Q2 2026, against a decline of 95.9% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $382 million (Q1 2026), $555.54 million (Q4 2025) and $82.66 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Jade Biosciences | 912.03 Mn | 912.03 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 950.97 Mn |
| Mar 31, 2026 | 382.00 Mn |
| Dec 31, 2025 | 555.54 Mn |
| Sep 30, 2025 | 82.66 Mn |
| Jun 30, 2025 | 105.00 Mn |
| Mar 31, 2025 | 2.47 Bn |
| Dec 31, 2024 | 2.50 Bn |
| Sep 30, 2024 | 2.02 Bn |
| Jun 30, 2024 | 1.57 Bn |
| Mar 31, 2024 | 28.77 Bn |
| Dec 31, 2023 | 21.87 Bn |
| Sep 30, 2023 | 13.00 Bn |
| Jun 30, 2023 | 16.42 Bn |
| Mar 31, 2023 | 17.40 Bn |
| Dec 31, 2022 | 25.22 Bn |
| Sep 30, 2022 | 14.08 Bn |
| Jun 30, 2022 | 13.21 Bn |
| Mar 31, 2022 | 15.50 Bn |
| Dec 31, 2021 | 4.91 Bn |
| Sep 30, 2021 | 17.74 Bn |
API Access
Jade Biosciences Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=JBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "JBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=JBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();